Oncolytic viruses as anticancer agents: clinical progress and remaining challenges
Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies to overcome resistance remain of crucial importance. Oncolytic viruses offer a promising approach, with the unique ability to selectively replicate within (and to destroy) can...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
18 September 2025
|
| In: |
The lancet
Year: 2025, Volume: 406, Issue: 10509, Pages: 1295-1312 |
| ISSN: | 1474-547X |
| DOI: | 10.1016/S0140-6736(25)01206-1 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/S0140-6736(25)01206-1 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0140673625012061 
|
| Author Notes: | Elizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, Alan Melcher, Richard Vile |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1951237153 | ||
| 003 | DE-627 | ||
| 005 | 20260205153941.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260205s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(25)01206-1 |2 doi | |
| 035 | |a (DE-627)1951237153 | ||
| 035 | |a (DE-599)KXP1951237153 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Appleton, Elizabeth |e VerfasserIn |0 (DE-588)1389076024 |0 (DE-627)1951238672 |4 aut | |
| 245 | 1 | 0 | |a Oncolytic viruses as anticancer agents |b clinical progress and remaining challenges |c Elizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, Alan Melcher, Richard Vile |
| 264 | 1 | |c 18 September 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.02.2026 | ||
| 520 | |a Immunotherapy has transformed the treatment of cancer, yet many patients do not have response or lasting benefit. Strategies to overcome resistance remain of crucial importance. Oncolytic viruses offer a promising approach, with the unique ability to selectively replicate within (and to destroy) cancer cells, remodel the immunosuppressive tumour microenvironment, and stimulate antitumour immunity. Interest in the potential of oncolytic viruses has grown steadily over the past two decades, fuelled by advances in cancer immunology and viral engineering. However, clinical translation has not kept pace, and although a plethora of promising new constructs have entered clinical testing, several barriers continue to restrict widespread clinical implementation. This Therapeutics paper highlights key milestones in oncolytic virus clinical development, discusses the challenges that remain, and, through clinical reflection, considers how future research might be streamlined to achieve meaningful benefit for patients. | ||
| 700 | 1 | |a Chiocca, E Antonio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ungerechts, Guy |d 1972- |e VerfasserIn |0 (DE-588)124557902 |0 (DE-627)363420053 |0 (DE-576)294230939 |4 aut | |
| 700 | 1 | |a Melcher, Alan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vile, Richard |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet |d London [u.a.] : Elsevier, 1823 |g 406(2025), 10509, Seite 1295-1312 |h Online-Ressource |w (DE-627)270128484 |w (DE-600)1476593-7 |w (DE-576)078590159 |x 1474-547X |7 nnas |a Oncolytic viruses as anticancer agents clinical progress and remaining challenges |
| 773 | 1 | 8 | |g volume:406 |g year:2025 |g number:10509 |g pages:1295-1312 |g extent:18 |a Oncolytic viruses as anticancer agents clinical progress and remaining challenges |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0140-6736(25)01206-1 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0140673625012061 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260205 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 124557902 |a Ungerechts, Guy |m 124557902:Ungerechts, Guy |d 910000 |d 910100 |d 50000 |e 910000PU124557902 |e 910100PU124557902 |e 50000PU124557902 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1951237153 |e 4877177698 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 05.02.2026"],"physDesc":[{"noteIll":"Illustrationen","extent":"18 S."}],"language":["eng"],"person":[{"given":"Elizabeth","family":"Appleton","role":"aut","display":"Appleton, Elizabeth"},{"family":"Chiocca","given":"E Antonio","role":"aut","display":"Chiocca, E Antonio"},{"role":"aut","display":"Ungerechts, Guy","given":"Guy","family":"Ungerechts"},{"display":"Melcher, Alan","role":"aut","given":"Alan","family":"Melcher"},{"display":"Vile, Richard","role":"aut","family":"Vile","given":"Richard"}],"id":{"eki":["1951237153"],"doi":["10.1016/S0140-6736(25)01206-1"]},"relHost":[{"part":{"year":"2025","pages":"1295-1312","text":"406(2025), 10509, Seite 1295-1312","extent":"18","issue":"10509","volume":"406"},"titleAlt":[{"title":"The lancet <London>"},{"title":"London lancet"},{"title":"Lancet (British ed. Online)"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"London [u.a.] ; London","dateIssuedDisp":"1823-","publisher":"Elsevier ; The Lancet Ltd.","dateIssuedKey":"1823"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"270128484","disp":"Oncolytic viruses as anticancer agents clinical progress and remaining challengesThe lancet","language":["eng"],"title":[{"title_sort":"lancet","title":"The lancet"}],"pubHistory":["1.1823 -"],"id":{"eki":["270128484"],"issn":["1474-547X"],"zdb":["1476593-7"]}}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"18 September 2025"}],"recId":"1951237153","type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"clinical progress and remaining challenges","title_sort":"Oncolytic viruses as anticancer agents","title":"Oncolytic viruses as anticancer agents"}],"name":{"displayForm":["Elizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, Alan Melcher, Richard Vile"]}} | ||
| SRT | |a APPLETONELONCOLYTICV1820 | ||